Optibiotix Health Share Discussion Threads

[john henry] 13/12/2016 07:20

Excellent news, imho there will be a deal with a MN to launch into the North American market very soon.

[someuwin] 13/12/2016 07:10

Excellent!

[tidy 2] 13/12/2016 07:09

Asians tend to be obese don't they !!

[whl2] 13/12/2016 07:06

Wasn't expecting that before Christmas - apologies to other long term holders

[larva] 13/12/2016 07:05

Another useless non announcement

[primal123] 13/12/2016 07:04

Joint Product Agreement with multinationalOptiBiotix Health plc (AIM: OPTI), a life sciences business developing products to tackle obesity, high cholesterol and diabetes, announces that it has entered into a joint development agreement (the "Agreement") with a multinational. The Agreement allows for the development of food and Over The Counter ("OTC") products containing OptiBiotix's SlimBiome(R) technology for the Asian market.The multinational is a major supplier of nutritional solutions to the food, beverage, nutraceutical and pharmaceutical industries within Asia, and increasingly across global markets.The aim of the Agreement is to develop weight management products containing SlimBiome(R) technology in a range of foods and OTC products which, if successful, will be launched into the Asian market in the second half of 2017.The Company requires its identity and commercial details to remain confidential and no further details can be disclosed at this time.Discussions are ongoing and it is hoped a further announcement can be made in due course.Stephen O'Hara, CEO of OptiBiotix, commented: "We are pleased to announce the signing of this Agreement with a multinational which creates the opportunity to launch products containing OptiBiotix's SlimBiome(R) into the Asian market next year. The multinational is a leading supplier of food ingredients with many well-known and respected brands and a multibillion dollar turnover. With India (30m) and China (46m) ranked second and third in having the highest number of overweight people in the world we hope that OptiBiotix's strong science base together with our partner's local knowledge, reputation, and sales and distribution capability will bring the benefits of SlimBiome(R) technology to a wider audience."

[judijudi] 13/12/2016 07:03

MN deal :)

[alphapig] 12/12/2016 17:38

"They can also cause nerve damage, and memory loss, because they reduce cholesterol" - I, as a layman, always thought reducing cholesterol was a healthy eating target?

[monkeywench1] 12/12/2016 13:54

Yes but you will have a long wait.

[mouse20] 12/12/2016 13:49

Yet another article in the telegraph today questioning the safety of statins.

Small extract below

"Besides the apparent benefit of statins, they appear to have a number of other effects,” says Uffe Ravnskov , a Danish physician who runs the International Network of Cholesterol Sceptics, a network for doctors and scientists. “Most commonly, statins can cause muscular weakness, or dystrophy, as well as diabetes and cancer. They can also cause nerve damage, and memory loss, because they reduce cholesterol, which is vital to brain function. These symptoms affect large numbers of patients, but people go on taking them because they’re too frightened of doctors to stop.”


Come spring and with a fair wind (and hopefully on a global scale), folks can start to reduce their reliance on statins. Then you are talking TW's telephone numbers. But the market has not yet cottoned on to this. Or don't believe it will be on such a scale. Time will tell.

[westmoreland lad] 12/12/2016 13:14

Very wise Curry !

[currypasty] 12/12/2016 13:02

buying at 63p today

[elrico] 10/12/2016 18:40

Given OPTI bought a controlling interest in UoM IP for skin care, etc, I can only ASSUME Cath O work is on said OPTI IP now - nothing else makes sense to me at any rate.

[whl2] 10/12/2016 18:26

Roll on 2017!

[john henry] 10/12/2016 18:05

Seems pretty obvious to me that J&J is one of the MN that will be involved with Skinbiotix. Agree F3 I think they will take a stake in the demerger company.

[f3rdinand] 10/12/2016 17:25

Yeah that's what I read too Elrico! Just wondering if she is working with them separately to OPTI or collaboratively! I'm personally expecting J&J to take a stake in Skinbiotix when it demerges! That should focus some minds!

[elrico] 10/12/2016 15:46

Johnson & Johnson Innovation team up with Manchester scientists Since 19 Jun 2014
As part of a strategy to explore the emerging science around the human microbiome and its impact across several areas of health and disease, Johnson & Johnson Consumer & Personal Products Worldwide and Johnson & Johnson Innovation have established a collaboration with scientists from The University of Manchester.
The collaboration will explore potential applications of probiotic extracts for prevention and treatment of skin, oral, and respiratory conditions.
Dr Catherine O’Neill, from the University’s Institute of Inflammation and Repair, and Dr Andrew McBain, from Manchester Pharmacy School, will lead on the research project with Johnson & Johnson Innovation.

Dr O’Neill said: “It’s exciting to be working with such a massive global player who we hope will really help us to develop products which will bring benefits to patients.

“This collaboration will help us co-develop a piece of technology established here in Manchester which uses probiotics – or friendly bacteria - on the skin and hopefully take this to market.”
The agreement underscores the approach Johnson & Johnson Innovation is taking to establish scientific collaborations in areas that span its pharmaceutical, medical device and diagnostics and consumer businesses.

[john henry] 10/12/2016 13:04

F3 i guess with her involvement with soon to be listed Skin bio then J&J are sure to be involved.

[f3rdinand] 10/12/2016 08:19

I do wonder where J&J fit into all this! Are they still working with Dr O'Neil developing understanding of the microbiome- does this now include OPTI?

[mazzstar] 09/12/2016 21:33

I wonder if Opti will partner with her other company, namely Curapel - it has three skin products in late stage development. hxxp://www.financewales.co.uk/news-and-features/news/2016/curapel.aspx

[warren1982] 09/12/2016 21:00

Nice one mazzstar, very interesting and a very enthusiastic Cath O'Neil, just a matter of being patient 2017 will be our year.
GLA.

[mazzstar] 09/12/2016 19:56

Interesting video on how Cath O'Neill formed Skinbiotix (starts around the 2 min mark):

[judijudi] 09/12/2016 17:50

The "must be news leaked" gang when we are 2p up are nearky as bad

[1bokke] 09/12/2016 17:45

Elrico, I'm free on Thurs afternoon. I might even buy him a colouring book...